| Total Wound Care Solutions | |
| 64 Central St, Georgetown, Massachusetts 01833 | |
| (888) 858-9988 |
| Name | Total Wound Care Solutions |
|---|---|
| Organization Name | Tidewater Medical, Inc. |
| Location | 64 Central St, Georgetown, Massachusetts 01833 |
| Type | Supplier |
| Phone | (888) 858-9988 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Researchers at the University of Louisville have uncovered a cadre of small molecules that tell certain proteins to kill lung cancer cells. The team, led by Chi Li, Ph.D., assistant professor of medicine, published its finding in the April 2014 issue of Molecular and Cellular Biology.
Emerald BioStructures, a leading provider of integrated structural biology services, and SomaLogic, Inc., a diagnostics and biomarker discovery company, today announced that they have entered into a strategic collaboration for the structure-based design of chemically modified DNA aptamers and small molecule therapeutics, based on crystal structures of important protein targets bound to high affinity SOMAmers.
BRD4 inhibitors are among the most promising new agents in cancer therapy that are currently evaluated in clinical trials.
A first-of-its-kind study discovered that women and minorities who underwent a percutaneous coronary intervention (PCI) are at a greater risk of experiencing recurrent cardiac events within the first year after their procedure compared to Caucasian men.
› Verified 6 days ago
News Archive
Researchers at the University of Louisville have uncovered a cadre of small molecules that tell certain proteins to kill lung cancer cells. The team, led by Chi Li, Ph.D., assistant professor of medicine, published its finding in the April 2014 issue of Molecular and Cellular Biology.
Emerald BioStructures, a leading provider of integrated structural biology services, and SomaLogic, Inc., a diagnostics and biomarker discovery company, today announced that they have entered into a strategic collaboration for the structure-based design of chemically modified DNA aptamers and small molecule therapeutics, based on crystal structures of important protein targets bound to high affinity SOMAmers.
BRD4 inhibitors are among the most promising new agents in cancer therapy that are currently evaluated in clinical trials.
A first-of-its-kind study discovered that women and minorities who underwent a percutaneous coronary intervention (PCI) are at a greater risk of experiencing recurrent cardiac events within the first year after their procedure compared to Caucasian men.
› Verified 6 days ago
Cvs Pharmacy # 02177 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 65 Central Street, Georgetown, Massachusetts 01833 Phone: (978) 352-8540 | |
Total Wound Care Solutions Type: Medicare Supplier Location: 64 Central St, Georgetown, Massachusetts 01833 Phone: (888) 858-9988 |